Fund Overview of Aditya Birla Sun Life Nifty Healthcare Etf-growth
-
₹36.6 CrAUM
-
₹15.25NAV
-
0.19%Expense Ratio
-
EquityFund Category
Returns of Aditya Birla Sun Life Nifty Healthcare Etf-growth
Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
---|---|---|---|
3 Months | 2.12% | NA | 6.12% |
6 Months | 12.65% | NA | 12.92% |
1 Year | 0.80% | 0.80% | 6.04% |
2 Years | 56.79% | 25.21% | 24.93% |
3 Years | 82.68% | 22.24% | 25.71% |
Asset Allocation
equities
99.98%other assets or cash equivalents
0.02%Aditya Birla Sun Life Nifty Healthcare Etf-growth is one Equity mutual fund offered by Aditya Birla Sun Life Mutual Fund. Launched on 20 Oct 2021, the fund aims Long term capital growth. Investments in stocks comprising the underlying index and endeavors to track the benchmark index. It manages assets worth ₹36.6 crore as on Thu Jul 31, 2025. , with a 52-week NAV range between ₹12.98 and ₹15.44. The expense ratio stands at 0.19%. Fund Manager Manager EducationAbout Aditya Birla Sun Life Nifty Healthcare Etf-growth
The portfolio allocation consists of 99.98% in equities, 0.02% in other assets or cash equivalents. Managed by Priya Sridhar, it has delivered a return of 0.80% in the last year, a total return since inception of 15.10%.
Key Metrics of Aditya Birla Sun Life Nifty Healthcare Etf-growth
-
Standard Deviation16.59%
-
Sharpe Ratio0.92%
-
Alpha-2.00%
-
Beta1.01%
Fund Details
|
|
Top Performing Mutual Funds
Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
---|---|---|---|---|---|---|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | -0.73% | -0.53% | 3.49% | 29.11% | 21.35% |
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | -0.81% | -0.74% | 2.62% | 28.00% | 20.28% |
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | -0.32% | 0.29% | -2.50% | 23.52% | 17.19% |
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | -0.41% | -0.03% | -3.76% | 21.87% | 15.52% |
More funds from Aditya Birla Sun Life Mutual Fund
Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
---|---|---|---|---|---|---|
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth
|
₹872 | -0.41% | -0.03% | 6.81% | -3.76% | 21.87% |
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth
|
₹872 | -0.32% | 0.29% | 7.48% | -2.50% | 23.52% |
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-idcw
|
₹872 | -0.41% | -0.03% | 6.81% | -3.76% | 21.87% |
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-idcw
|
₹872 | -0.32% | 0.29% | 7.48% | -2.50% | 23.52% |
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
---|---|---|---|---|---|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹43.62 | 29.11% | 21.35% | - |
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹40.40 | 28.00% | 20.28% | - |
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹31.25 | 21.87% | 15.52% | - |
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹34.42 | 23.52% | 17.19% | - |
Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.25 | 22.46% | - | - |
Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.25 | 22.46% | - | - |
Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.25 | 22.46% | - | - |
Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.25 | 22.46% | - | - |
Detailed Portfolio
Stocks | Sector | % of Holding | Value |
---|---|---|---|
Sun Pharmaceutical Industries Ltd | Healthcare | 18.51% | ₹6.77 Cr |
Sun Pharmaceutical Industries Ltd | Healthcare | 17.79% | ₹6.41 Cr |
Sun Pharmaceutical Industries Ltd | Healthcare | 17.79% | ₹6.41 Cr |
Max Healthcare Institute Ltd | Healthcare | 9.32% | ₹3.41 Cr |
Cipla Ltd | Healthcare | 8.95% | ₹3.22 Cr |
Cipla Ltd | Healthcare | 8.95% | ₹3.22 Cr |
Cipla Ltd | Healthcare | 8.80% | ₹3.22 Cr |
Max Healthcare Institute Ltd | Healthcare | 8.77% | ₹3.16 Cr |
Max Healthcare Institute Ltd | Healthcare | 8.77% | ₹3.16 Cr |
Divi's Laboratories Ltd | Healthcare | 8.43% | ₹3.08 Cr |
Apollo Hospitals Enterprise Ltd | Healthcare | 7.92% | ₹2.85 Cr |
Apollo Hospitals Enterprise Ltd | Healthcare | 7.92% | ₹2.85 Cr |
Dr. Reddy's Laboratories Ltd | Healthcare | 7.78% | ₹2.85 Cr |
Dr. Reddy's Laboratories Ltd | Healthcare | 7.89% | ₹2.84 Cr |
Dr. Reddy's Laboratories Ltd | Healthcare | 7.89% | ₹2.84 Cr |
Apollo Hospitals Enterprise Ltd | Healthcare | 7.62% | ₹2.79 Cr |
Divi's Laboratories Ltd | Healthcare | 7.65% | ₹2.76 Cr |
Divi's Laboratories Ltd | Healthcare | 7.65% | ₹2.76 Cr |
Fortis Healthcare Ltd | Healthcare | 5.35% | ₹1.93 Cr |
Fortis Healthcare Ltd | Healthcare | 5.35% | ₹1.93 Cr |
Lupin Ltd | Healthcare | 4.89% | ₹1.76 Cr |
Lupin Ltd | Healthcare | 4.89% | ₹1.76 Cr |
Lupin Ltd | Healthcare | 4.69% | ₹1.72 Cr |
Fortis Healthcare Ltd | Healthcare | 4.50% | ₹1.64 Cr |
Torrent Pharmaceuticals Ltd | Healthcare | 3.94% | ₹1.44 Cr |
Torrent Pharmaceuticals Ltd | Healthcare | 3.99% | ₹1.44 Cr |
Torrent Pharmaceuticals Ltd | Healthcare | 3.99% | ₹1.44 Cr |
Laurus Labs Ltd | Healthcare | 3.44% | ₹1.26 Cr |
Laurus Labs Ltd | Healthcare | 3.46% | ₹1.25 Cr |
Laurus Labs Ltd | Healthcare | 3.46% | ₹1.25 Cr |
Glenmark Pharmaceuticals Ltd | Healthcare | 3.23% | ₹1.18 Cr |
Aurobindo Pharma Ltd | Healthcare | 3.21% | ₹1.17 Cr |
Alkem Laboratories Ltd | Healthcare | 3.23% | ₹1.16 Cr |
Alkem Laboratories Ltd | Healthcare | 3.23% | ₹1.16 Cr |
Aurobindo Pharma Ltd | Healthcare | 3.21% | ₹1.16 Cr |
Aurobindo Pharma Ltd | Healthcare | 3.21% | ₹1.16 Cr |
Glenmark Pharmaceuticals Ltd | Healthcare | 3.11% | ₹1.12 Cr |
Glenmark Pharmaceuticals Ltd | Healthcare | 3.11% | ₹1.12 Cr |
Mankind Pharma Ltd. | Healthcare | 2.92% | ₹1.07 Cr |
Mankind Pharma Ltd. | Healthcare | 2.91% | ₹1.05 Cr |
Mankind Pharma Ltd. | Healthcare | 2.91% | ₹1.05 Cr |
Alkem Laboratories Ltd | Healthcare | 2.72% | ₹1.00 Cr |
Zydus Lifesciences Ltd | Healthcare | 2.60% | ₹0.94 Cr |
Zydus Lifesciences Ltd | Healthcare | 2.60% | ₹0.94 Cr |
Zydus Lifesciences Ltd | Healthcare | 2.44% | ₹0.89 Cr |
Biocon Ltd | Healthcare | 2.36% | ₹0.86 Cr |
Biocon Ltd | Healthcare | 2.17% | ₹0.78 Cr |
Biocon Ltd | Healthcare | 2.17% | ₹0.78 Cr |
Ipca Laboratories Ltd | Healthcare | 2.06% | ₹0.75 Cr |
Ipca Laboratories Ltd | Healthcare | 1.97% | ₹0.71 Cr |
Ipca Laboratories Ltd | Healthcare | 1.97% | ₹0.71 Cr |
Abbott India Ltd | Healthcare | 1.80% | ₹0.66 Cr |
Abbott India Ltd | Healthcare | 1.62% | ₹0.58 Cr |
Abbott India Ltd | Healthcare | 1.62% | ₹0.58 Cr |
Syngene International Ltd | Healthcare | 1.36% | ₹0.50 Cr |
Syngene International Ltd | Healthcare | 1.25% | ₹0.45 Cr |
Piramal Pharma Ltd | Healthcare | 1.25% | ₹0.45 Cr |
Syngene International Ltd | Healthcare | 1.25% | ₹0.45 Cr |
Piramal Pharma Ltd | Healthcare | 1.25% | ₹0.45 Cr |
Reverse Repo | Unspecified | 0.92% | ₹0.33 Cr |
Reverse Repo | Unspecified | 0.92% | ₹0.33 Cr |
Granules India Ltd | Healthcare | 0.69% | ₹0.25 Cr |
Net Receivables | Unspecified | 0.18% | ₹0.07 Cr |
Net Payables | Unspecified | -0.90% | ₹-0.32 Cr |
Net Payables | Unspecified | -0.90% | ₹-0.32 Cr |
Top Equity Funds
Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
---|---|---|---|---|
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹43.62 | 29.11% | 21.35% | 44.69 |
ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹40.40 | 28.00% | 20.28% | 41.47 |
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹34.42 | 23.52% | 17.19% | - |
Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹31.25 | 21.87% | 15.52% | - |
Aditya Birla Sun Life Nifty Healthcare Etf-growth
What is the current AUM of Aditya Birla Sun Life Nifty Healthcare Etf-growth?
As of Thu Jul 31, 2025, Aditya Birla Sun Life Nifty Healthcare Etf-growth manages assets worth ₹36.6 crore
How has Aditya Birla Sun Life Nifty Healthcare Etf-growth performed recently?
- 3 Months: 2.12%
- 6 Months: 12.65%
What is the long-term performance of Aditya Birla Sun Life Nifty Healthcare Etf-growth?
- 3 Years CAGR: 22.24%
- Since Inception: 15.10%
What is the portfolio composition of Aditya Birla Sun Life Nifty Healthcare Etf-growth?
Equity: 99.98%, Others: 0.02%.
Who manages Aditya Birla Sun Life Nifty Healthcare Etf-growth?
Aditya Birla Sun Life Nifty Healthcare Etf-growth is managed by Priya Sridhar from Aditya Birla Sun Life Mutual Fund.
What is the market-cap allocation of Aditya Birla Sun Life Nifty Healthcare Etf-growth?
Large Cap: 73.37%, Mid Cap: 24.12%, Small Cap: 2.50%.
Which are the top companies Aditya Birla Sun Life Nifty Healthcare Etf-growth has invested in?
- Sun Pharmaceutical Industries Ltd – 18.51% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 17.79% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 17.79% of the fund's portfolio
- Max Healthcare Institute Ltd – 9.32% of the fund's portfolio
- Cipla Ltd – 8.95% of the fund's portfolio
Which are the major sectors Aditya Birla Sun Life Nifty Healthcare Etf-growth focuses on?
- Healthcare – 299.79% of the fund's portfolio
- Unspecified – 0.21% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.